<DOC>
	<DOC>NCT01251588</DOC>
	<brief_summary>The objective of this study is to examine the 5-year efficacy and safety of Matrix-Induced Autologous Chondrocyte Implantation (MACI® Implant), compared with arthroscopic microfracture, in patients who received study treatment in Genzyme-sponsored study MACI00206 [NCT00719576] for treatment of symptomatic articular cartilage defects of the femoral condyle, including the trochlea.</brief_summary>
	<brief_title>Extension Study for Participants of Previous Study MACI00206 [NCT00719576] of MACI® Implant for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle</brief_title>
	<detailed_description />
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Patients that received study treatment (MACI implant or microfracture) in the MACI00206 [NCT00719576] study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cartilage legions,</keyword>
	<keyword>Symptomatic focal cartilage defects,</keyword>
	<keyword>Microfracture,</keyword>
	<keyword>MACI,</keyword>
	<keyword>Autologous chondrocyte,</keyword>
	<keyword>Trochlea</keyword>
</DOC>